Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
SEC-verified vehicles of the same sponsor, predating these roles and carrying none of them. The badge counts them; the figure beside this one does not.
Mergers closed across all 3 — these vehicles and the franchise's earlier ones together.
Announced but not closed, and still hunting — again over all 3.
No closed vehicle here has both a stored price and a filed trust value to score it against.
2 vehicles on file, newest listing first
3 of 7 appear on more than one
5 people on two or more of them
Verender S. Badial is a London-based strategic investor, SEC-regulated chief financial officer, and former investment banker with over two decades of leadership across global capital markets, mergers and acquisitions, special purpose acquisition companies, and strategic growth initiatives. He currently serves as Chief Executive Officer and Director of ME Asset Management Ltd, a UK property investment firm he has led since July 2025, focused on acquiring and repositioning income-producing real estate affected by building safety and regulatory complexities. In parallel, he serves as a Board Member and Chair of the Audit Committee at JATT II Acquisition Corp (NASDAQ: JATT), a special purpose acquisition company that raised $60 million in its April 2026 initial public offering of six million units priced at $10 each, with an investor-aligned structure consisting solely of ordinary shares and no warrants or rights attached. JATT II is focused on identifying and completing a business combination with a healthcare or healthcare-related target, with particular emphasis on biotechnology and the broader life sciences sector. Badial also holds a current advisory role with JAAQ (Just Ask A Question), a free mental health platform launched in 2025 that allows users to explore over sixty topics by posing questions and receiving video answers from experts and individuals with lived experience.
Badial's most prominent SPAC track record centers on his role as Co-Founder, Sponsor, and Chief Financial Officer of JATT Acquisition Corp, a NYSE-listed special purpose acquisition company that raised $138 million. He was a key architect of that vehicle's successful de-SPAC transaction, widely recognized as one of the few successful UK-founded de-SPAC deals managed entirely from the United Kingdom. In March 2023, JATT Acquisition Corp completed its business combination with Zura Bio, a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, and Badial transitioned into the role of Chief Financial Officer at the newly public Nasdaq-listed entity. At Zura Bio, he led the development of internal financial and operational systems, helped shape financial strategy, participated in capital-raising efforts that supported the company's early growth, and oversaw the raising of over $273 million in post-merger capital to drive expansion. He remained with Zura Bio as a non-executive director through July 31, 2025, to ensure a seamless transition following the appointment of his successor, Eric Hyllengren, and was publicly thanked by the board for his contributions. His earlier board service includes a tenure as Board Director of Mackenzie Homes Ltd from December 2015 to November 2018.
Beyond his corporate roles, Badial is a Founding Member of Kontaktsource, a membership-based organization that connects professionals in mergers and acquisitions, private equity, investment banking, and family offices through networking events and an online community. He has also served since January 1992 as Director of Fundraising for the College of Nursing, Public Khalsa College for Women, an institution that has grown from an idea into a school educating over 2,000 women and girls in science and nursing. His professional profile on The Marque highlights a career recognized for raising and deploying capital from private equity, institutional investors, and family offices, with a track record spanning biotechnology, technology, and large-scale real estate, consistently scaling high-growth ventures and delivering long-term shareholder value.
Badial's educational background includes a Bachelor of Science in Actuarial Science from the London School of Economics, completed between 1990 and 1994, followed by study at the Financial Options Research Centre at Warwick Business School, University of Warwick, from 1994 to 1996. His career has encompassed investment banking, CFO leadership at multiple public companies, SPAC spons
This record is keyed to SEC CIK 0001870327 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 9 institutional-holder rows on these vehicles, under 7 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.